Abstract
The aim of molecular tumor board (MTB) is to identify potential therapeutic strategies, based on genetic analysis, for patients (pts) not responding to standard therapies. All tumor types are eligible for MTB discussion and sarcomas are one of common target due to low number of standard and innovative treatments. Here we analyze the role of MTB in a sarcoma referral center.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have